Reply to thread

Problem is that stem cells research do not revolve only around the United States. Other countries that have same or similar research protocols and clinical trial guidelines are more apt to move faster to get things done. FDA is notoriously know for their slowness in approving medical procedures despite having a fast track option which may shave off only a few years worth of waiting.


Back
Top